Concepedia

Jeroen van de Wetering

JV

Statistics

Publications

3

Citations

117

H-Index

3

Active since

2013

Affiliations

Teva Pharmaceuticals (Israel)(Current)

Jeroen van de Wetering is an author at Teva Pharmaceuticals (Israel) specializing in drug discovery, medicine, and pharmacotherapy.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyPharmacokineticsAddictionNeurologyPhysiologyToxicologyMetabolomics

Publications per year

2013–2021

3

Publications

3

Safety, pharmacokinetics, and pharmacodynamics of TV‐1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects

Orit Cohen‐Barak, Jacqueline Wildeman, Jeroen van de Wetering et al. · The Journal of Clinical Pharmacology · 2014 · 62 citations · Full text

Healthy Subjects, Psychotropic Medication, Pharmacotherapy +18

The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol

Walter Krauwinkel, James Dickinson, Marloes Schaddelee et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2013 · 45 citations

Molecular Pharmacology, Pharmacological Study, Drug Discovery +10

A Single Administration of AZP-3601, a Novel, Long-Acting PTH Analog, Induces a Significant and Sustained Calcemic Response: Preliminary Data From a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

Soraya Allas, Michel Ovize, Michael D. Culler et al. · Journal of the Endocrine Society · 2021 · 10 citations · Full text

1–3 of 3